Review
Copyright ©The Author(s) 2020.
World J Clin Cases. Jun 6, 2020; 8(11): 2066-2080
Published online Jun 6, 2020. doi: 10.12998/wjcc.v8.i11.2066
Figure 1
Figure 1 The liquid biopsy markers commonly used for cancer screening and surveillance. With the rapid development of molecular biological technology, the liquid biopsy markers, including circulating free DNA, circulating tumor DNA, circulating tumor cells, microRNAs and exosomes can be clinically employed to detect early tumor generation and metastasis. cfDNA: Circulating free DNA; ctDNA: Circulating tumor DNA; CTCs: Circulating tumor cells; miRNA: MicroRNAs; dPCR: Digital polymerase chain reaction; FCM: The fuzzy c-means; LT-PCR: Long template polymerase chain reaction; TEC-Seq: Targeted error correction sequencing.